Indeed, it has been previously shown that CD39 and CD103 co-expression identifies a subpopulation of TILs found in tumor microenvironment, with a TRM phenotype, expressing high levels of exhaustion markers, and enriched in tumor reactive T cells. This evidence concerns the gene ENTPD1 and neoplasm.